Imperial College London

Dr Evangelos Triantafyllou

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Lecturer in Liver Immunology



e.triantafyllou Website




10.N12ACommonwealth BuildingHammersmith Campus




College/Department roles

  • Member of the People and Culture Committee
  • Member of the Higher Degrees Research Committee
  • Section Rep (Hepatology and Gastroenterology)
  • Postdoc and Fellow Champion 

Student supervision

BSc and MSc

Primary Supervisor

  • BSc Gastroenterology and Hepatology: Hagger Georgina (2023), Turic Anya (2021), O' Connor Thomas (2020)
  • BSc Biomedical Sciences: Lee Ruby (2023)
  • MSc Immunology: Morel Sarah (2023), Husbyn Hannah (2019)


  • BSc Gastroenterology and Hepatology: Dance Matsutani Tsubasa (2023)
  • BSc Biomedical Sciences: Liu Yi (2022)
  • MSc Immunology: Asmonaite Brigita (2023), Mathur Anandita (2023)


Primary Supervisor

  • Patseas Dimitrios, "Immune dysregulation and therapeutic immunomodulation in chronic liver disease" (PhD at Imperial College London)


  • Sheth Roosey, "Checkpoint inhibitors for immune regulation in liver failure syndromes" (PhD at King's College London)
  • Delo Joseph, "Dynamic expression of immune checkpoints on immune cells in patients at different stages of liver disease and their role in cirrhosis associated immune dysfunction" (PhD at St George's University London)
  • Artru Florent, "Impact of effective albumin concentration on key eicosanoids circulating level and immune dysfunction in severe alcoholic hepatitis and ACLF: an translational prospective study" (PhD at King's College London)
  • Mukherjee Sujit, "MerTK expressing macrophages in hepatocellular carcinoma: a potential novel immunotherapeutic target" (PhD at Imperial College London)

Assistant Supervisor

  • Gudd Cathrin, "Understanding the pathogenesis of immune checkpoint inhibitor-induced hepatitis" (PhD at Imperial College London)
  • Singanayagam Arjuna, "Modulation of MER tyrosine kinase signalling in liver failure: a therapeutic strategy to reverse immuneparesis and susceptibility to infection" (PhD at Imperial College London)